Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik H Knelson

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Trends in Biochemical Sciences|April 24, 2014
Heparan sulfate signaling in cancerErik H Knelson, Jasmine C Nee, Gerard C Blobe
Cancers|February 13, 2021
PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve ResponsesErik H Knelson, Shetal A Patel, Jacob M Sands
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 9, 2017
Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiationAngela L Gaviglio, Erik H Knelson, Gerard C Blobe
The Biochemical Journal|June 12, 2013
The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cellsSun Young Oh, Erik H Knelson, Gerard C Blobe, et al.
Expert Opinion on Therapeutic Targets|March 11, 2021
KRAS G12C inhibition and innate immune targetingTetsuo Tani, Shunsuke Kitajima, Ella B Conway, et al.
American Journal of Medical Genetics. Part A|February 13, 2013
Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locusDavid Van Mater, Erik H Knelson, Kathleen A Kaiser-Rogers, et al.
Cancers|July 27, 2022
Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer ImmunotherapiesMarco Campisi, Sarah E Shelton, Minyue Chen, et al.
The Journal of Clinical Investigation|November 13, 2013
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastomaErik H Knelson, Angela L Gaviglio, Alok K Tewari, et al.
The Journal of Clinical Investigation|June 18, 2014
Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growthErik H Knelson, Angela L Gaviglio, Jasmine C Nee, et al.
Frontiers in Oncology|May 24, 2021
Surgical and Peri-Operative Considerations for Brain MetastasesSaksham Gupta, Hassan Dawood, Alexandra Giantini Larsen, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Trends in Biochemical Sciences|April 24, 2014
Heparan sulfate signaling in cancerErik H Knelson, Jasmine C Nee, Gerard C Blobe
Cancers|February 13, 2021
PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve ResponsesErik H Knelson, Shetal A Patel, Jacob M Sands
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 9, 2017
Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiationAngela L Gaviglio, Erik H Knelson, Gerard C Blobe
The Biochemical Journal|June 12, 2013
The type III TGFβ receptor regulates filopodia formation via a Cdc42-mediated IRSp53-N-WASP interaction in epithelial cellsSun Young Oh, Erik H Knelson, Gerard C Blobe, et al.
Expert Opinion on Therapeutic Targets|March 11, 2021
KRAS G12C inhibition and innate immune targetingTetsuo Tani, Shunsuke Kitajima, Ella B Conway, et al.
American Journal of Medical Genetics. Part A|February 13, 2013
Neuroblastoma in a pediatric patient with a microduplication of 2p involving the MYCN locusDavid Van Mater, Erik H Knelson, Kathleen A Kaiser-Rogers, et al.
Cancers|July 27, 2022
Engineered Microphysiological Systems for Testing Effectiveness of Cell-Based Cancer ImmunotherapiesMarco Campisi, Sarah E Shelton, Minyue Chen, et al.
The Journal of Clinical Investigation|November 13, 2013
Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastomaErik H Knelson, Angela L Gaviglio, Alok K Tewari, et al.
The Journal of Clinical Investigation|June 18, 2014
Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growthErik H Knelson, Angela L Gaviglio, Jasmine C Nee, et al.
Frontiers in Oncology|May 24, 2021
Surgical and Peri-Operative Considerations for Brain MetastasesSaksham Gupta, Hassan Dawood, Alexandra Giantini Larsen, et al.
Pageof 3